Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 20, 2024

BUY
$37.61 - $45.72 $2,106 - $2,560
56 New
56 $2,000
Q4 2022

Feb 03, 2023

SELL
$31.9 - $41.95 $127 - $167
-4 Reduced 6.67%
56 $2,000
Q3 2022

Nov 10, 2022

BUY
$29.83 - $38.01 $1,789 - $2,280
60 New
60 $2,000
Q3 2018

Nov 01, 2018

SELL
$52.95 - $71.34 $1,323 - $1,783
-25 Closed
0 $0
Q3 2017

Nov 15, 2017

BUY
$43.46 - $52.49 $1,086 - $1,312
25 New
25 $2,000
Q3 2017

Nov 14, 2017

SELL
$43.46 - $52.49 $1,086 - $1,312
-25 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
25
25 $1,000

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $973M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.